Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Clinicopathological Features and Survival of Colorectal Cancer Patients Younger Than 50 Years: A Retrospective Comparative Study Publisher Pubmed



Ghodssighassemabadi R1 ; Hajizadeh E1 ; Kamian S2 ; Mahmoudi M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biostatistics, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  2. 2. Shahid Beheshti University of Medical Sciences, Imam Hossein Hospital, Tehran, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of the Egyptian National Cancer Institute Published:2019


Abstract

Background: Colorectal cancer (CRC) is a disease of old age, but its incidence has been rising among younger population compared to older ones. Nevertheless, there is a controversy over survival of younger patients compared to the older ones. Therefore, in the current study, we investigated the clinicopathological features and survival of the younger (< 50 years) versus older (≥ 50 years) CRC patients. Results: The younger and older groups consisted of 39.4% and 60.6% of patients, respectively. Both age groups were comparable regarding the symptom presentation and duration, and pre-operative carcinoembryonic antigen (CEA). The younger patients were diagnosed with a higher proportion of poorly differentiated (14.7% vs. 8.3%; p < 0.001) and more advanced tumors (53.2% vs. 45.9%; p = 0.266). The rectum tumor site was significantly more common among the younger patients (p = 0.021). The overall survival (OS) (p = 0.278), the cancer-specific survival (CSS) (p = 0.233), and the disease-free survival (DFS) (p = 0.497) did not differ significantly between the two groups. Based on Cox regression model, elevated pre-operative CEA level (HR = 1.41; 95%CI of 1.01–1.97), advanced tumor stage (6.06; 95%CI of 3.03–12.15), and poorly differentiated tumor (HR = 1.69; 95%CI of 1.05–2.71) were associated with decreased survival. Conclusions: The younger patients did not have poor prognosis compared to the older ones despite having an advanced tumor stage and a poor tumor differentiation. © 2019, The Author(s).